Single-cell chromatin accessibility and transcriptomic characterization of Behcet's disease.


Journal

Communications biology
ISSN: 2399-3642
Titre abrégé: Commun Biol
Pays: England
ID NLM: 101719179

Informations de publication

Date de publication:
17 10 2023
Historique:
received: 06 04 2023
accepted: 04 10 2023
medline: 23 10 2023
pubmed: 18 10 2023
entrez: 17 10 2023
Statut: epublish

Résumé

Behect's disease is a chronic vasculitis characterized by complex multi-organ immune aberrations. However, a comprehensive understanding of the gene-regulatory profile of peripheral autoimmunity and the diverse immune responses across distinct cell types in Behcet's disease (BD) is still lacking. Here, we present a multi-omic single-cell study of 424,817 cells in BD patients and non-BD individuals. This study maps chromatin accessibility and gene expression in the same biological samples, unraveling vast cellular heterogeneity. We identify widespread cell-type-specific, disease-associated active and pro-inflammatory immunity in both transcript and epigenomic aspects. Notably, integrative multi-omic analysis reveals putative TF regulators that might contribute to chromatin accessibility and gene expression in BD. Moreover, we predicted gene-regulatory networks within nominated TF activators, including AP-1, NF-kB, and ETS transcript factor families, which may regulate cellular interaction and govern inflammation. Our study illustrates the epigenetic and transcriptional landscape in BD peripheral blood and expands understanding of potential epigenomic immunopathology in this disease.

Identifiants

pubmed: 37848613
doi: 10.1038/s42003-023-05420-x
pii: 10.1038/s42003-023-05420-x
pmc: PMC10582193
doi:

Substances chimiques

Chromatin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1048

Informations de copyright

© 2023. Springer Nature Limited.

Références

J Autoimmun. 2016 Jun;70:73-9
pubmed: 27102145
Cell. 2020 Nov 12;183(4):1103-1116.e20
pubmed: 33098772
Autoimmun Rev. 2012 Oct;11(12):918-24
pubmed: 23010632
J Immunol. 2015 Apr 1;194(7):2999-3010
pubmed: 25712216
Clin Exp Rheumatol. 2008 Jul-Aug;26(4 Suppl 50):S59-63
pubmed: 19026117
Nat Rev Dis Primers. 2021 Sep 16;7(1):67
pubmed: 34531393
Nat Genet. 2008 May;40(5):553-9
pubmed: 18443593
Nat Methods. 2021 Nov;18(11):1333-1341
pubmed: 34725479
Nat Genet. 2021 Apr;53(4):455-466
pubmed: 33795864
Nat Genet. 2021 Mar;53(3):403-411
pubmed: 33633365
Nat Genet. 2017 Nov;49(11):1602-1612
pubmed: 28945252
Proc Natl Acad Sci U S A. 2021 Aug 17;118(33):
pubmed: 34385315
Curr Drug Targets. 2020;21(16):1652-1663
pubmed: 32682369
Arthritis Res Ther. 2022 Aug 8;24(1):186
pubmed: 35941595
Nat Immunol. 2011 Jul 03;12(8):778-85
pubmed: 21725321
J Exp Med. 2021 Jan 4;218(1):
pubmed: 32991667
J Immunol. 1994 Jun 15;152(12):5643-52
pubmed: 7515910
Immunity. 2019 Sep 17;51(3):451-464.e6
pubmed: 31471108
Proc Natl Acad Sci U S A. 2022 Jun 28;119(26):e2204289119
pubmed: 35727985
Eur J Immunol. 2006 May;36(5):1254-66
pubmed: 16619292
Nucleic Acids Res. 2020 Jan 8;48(D1):D87-D92
pubmed: 31701148
Mol Cell Biol. 2002 Nov;22(21):7439-48
pubmed: 12370291
Immunology. 1999 May;97(1):159-65
pubmed: 10447727
Int J Mol Sci. 2019 Jun 02;20(11):
pubmed: 31159473
Nat Genet. 2019 Jan;51(1):128-137
pubmed: 30478436
Cell Immunol. 2012 Nov;280(1):16-21
pubmed: 23246831
Immunity. 2006 May;24(5):563-74
pubmed: 16713974
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Science. 2022 Apr 15;376(6590):eabi9591
pubmed: 35258337
Cell. 2021 Jun 24;184(13):3573-3587.e29
pubmed: 34062119
Nat Immunol. 2012 Dec;13(12):1162-70
pubmed: 23086447
Front Immunol. 2021 Feb 25;12:622306
pubmed: 33717125
Commun Biol. 2022 May 26;5(1):506
pubmed: 35618758
Commun Biol. 2023 Oct 17;6(1):1048
pubmed: 37848613
Nat Cell Biol. 2021 Jun;23(6):620-630
pubmed: 34108657
Nat Genet. 2019 Apr;51(4):683-693
pubmed: 30858613
Nature. 2021 Jun;594(7863):398-402
pubmed: 34012112
Nat Immunol. 2009 Feb;10(2):203-13
pubmed: 19122653
Cell. 2018 Aug 23;174(5):1309-1324.e18
pubmed: 30078704
Cell. 2018 Jul 26;174(3):716-729.e27
pubmed: 29961576
J Immunol. 2014 Nov 15;193(10):4914-4923
pubmed: 25288570
Nat Immunol. 2019 Aug;20(8):1035-1045
pubmed: 31235953
Nat Commun. 2018 Dec 17;9(1):5344
pubmed: 30559442
Am J Hum Genet. 2014 Apr 3;94(4):559-73
pubmed: 24702953
Cell. 2014 Sep 11;158(6):1431-1443
pubmed: 25215497
Arthritis Rheum. 2004 Jul;50(7):2291-5
pubmed: 15248229
J Immunol. 2015 Jan 1;194(1):177-86
pubmed: 25472994
Cell Genom. 2022 Mar 9;2(3):
pubmed: 35434692
Front Immunol. 2022 Sep 29;13:1001201
pubmed: 36248862
Nat Biotechnol. 2019 Aug;37(8):925-936
pubmed: 31375813
Blood Adv. 2017 Nov 21;1(25):2348-2360
pubmed: 29296885
Rheumatology (Oxford). 2004 Jul;43(7):843-51
pubmed: 15150429
Nat Genet. 2021 Aug;53(8):1143-1155
pubmed: 34239132
Nat Biotechnol. 2018 Jun;36(5):411-420
pubmed: 29608179
J Rheumatol. 1999 Apr;26(4):826-32
pubmed: 10229403
Nat Rev Immunol. 2020 Jun;20(6):375-388
pubmed: 32132681
J Clin Med. 2017 Jul 21;6(7):
pubmed: 28753995
Nat Rev Rheumatol. 2018 Jan 24;14(2):119
pubmed: 29362466
Int J Immunogenet. 2018 Jun;45(3):128-137
pubmed: 29663655
Nat Biotechnol. 2019 Dec;37(12):1458-1465
pubmed: 31792411
J Leukoc Biol. 2012 Feb;91(2):299-309
pubmed: 22045868
Nat Methods. 2017 Oct;14(10):975-978
pubmed: 28825706
Nat Genet. 2015 Nov;47(11):1228-35
pubmed: 26414678
Genome Biol. 2008;9(9):R137
pubmed: 18798982
Mucosal Immunol. 2019 Sep;12(5):1104-1117
pubmed: 31285535
Bioinformatics. 2015 Jul 15;31(14):2382-3
pubmed: 25765347
J Immunol. 2016 May 1;196(9):3581-94
pubmed: 26983787
Surv Ophthalmol. 2005 Jul-Aug;50(4):297-350
pubmed: 15967189
J Immunol. 2018 Apr 1;200(7):2231-2233
pubmed: 29555676
Front Pharmacol. 2021 Sep 14;12:754933
pubmed: 34594230
Clin Immunol. 2001 Jun;99(3):373-7
pubmed: 11358434
Open Biol. 2020 Jan;10(1):190221
pubmed: 31937202
Nat Rev Immunol. 2012 Feb 17;12(3):191-200
pubmed: 22343568
J Immunol. 2009 Nov 15;183(10):6513-21
pubmed: 19841192
Nature. 2015 Feb 19;518(7539):337-43
pubmed: 25363779
Nat Genet. 2020 Nov;52(11):1158-1168
pubmed: 33106633
Arthritis Res Ther. 2018 Aug 2;20(1):161
pubmed: 30071881
Science. 2012 Sep 7;337(6099):1190-5
pubmed: 22955828
Nature. 2018 Dec;564(7735):268-272
pubmed: 30479382
Arthritis Rheum. 2005 Jun;52(6):1836-42
pubmed: 15934084
Arch Dermatol Res. 2018 Mar;310(2):127-138
pubmed: 29255925
Front Immunol. 2022 Jun 02;13:906499
pubmed: 35720357
Cell. 2021 Sep 16;184(19):5053-5069.e23
pubmed: 34390642
Nat Commun. 2019 Apr 3;10(1):1523
pubmed: 30944313
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Front Immunol. 2019 Mar 29;10:665
pubmed: 30984205
Nat Commun. 2020 Nov 30;11(1):6077
pubmed: 33257685
Cell Rep. 2020 Sep 22;32(12):108180
pubmed: 32966789
Nat Genet. 2013 Feb;45(2):202-7
pubmed: 23291587
Mol Immunol. 2004 May;41(1):53-62
pubmed: 15140575
J Allergy Clin Immunol. 2012 Mar;129(3):814-824.e6
pubmed: 22112519
F1000Res. 2020 Apr 1;9:223
pubmed: 32765839
Front Immunol. 2021 Aug 09;12:716469
pubmed: 34434197
J Biol Chem. 2023 Jan;299(1):102741
pubmed: 36435199
Cell Stem Cell. 2021 Mar 4;28(3):472-487.e7
pubmed: 33352111
Front Immunol. 2021 Mar 18;12:602539
pubmed: 33815362
Nat Commun. 2022 Apr 26;13(1):2240
pubmed: 35474218
Eur J Immunol. 2005 Jul;35(7):2071-80
pubmed: 15940674
J Eur Acad Dermatol Venereol. 2014 Mar;28(3):338-47
pubmed: 23441863
Cell Genom. 2022 Sep 14;2(9):
pubmed: 36204155
Blood. 2010 Nov 4;116(18):3465-74
pubmed: 20660289
Autoimmun Rev. 2007 Mar;6(4):237-40
pubmed: 17317615

Auteurs

Wen Shi (W)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, 510060, Guangzhou, China.
Research Unit of Ocular Development and Regeneration, Chinese Academy of Medical Sciences, 100085, Beijing, China.

Jinguo Ye (J)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, 510060, Guangzhou, China.

Zhuoxing Shi (Z)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, 510060, Guangzhou, China.

Caineng Pan (C)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, 510060, Guangzhou, China.

Qikai Zhang (Q)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, 510060, Guangzhou, China.

Yuheng Lin (Y)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, 510060, Guangzhou, China.

Dan Liang (D)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, 510060, Guangzhou, China. liangdan@gzzoc.com.

Yizhi Liu (Y)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, 510060, Guangzhou, China. liuyizh@mail.sysu.edu.cn.
Research Unit of Ocular Development and Regeneration, Chinese Academy of Medical Sciences, 100085, Beijing, China. liuyizh@mail.sysu.edu.cn.

Xianchai Lin (X)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, 510060, Guangzhou, China. linxch7@mail.sysu.edu.cn.
Research Unit of Ocular Development and Regeneration, Chinese Academy of Medical Sciences, 100085, Beijing, China. linxch7@mail.sysu.edu.cn.

Yingfeng Zheng (Y)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, 510060, Guangzhou, China. zhyfeng@mail.sysu.edu.cn.
Research Unit of Ocular Development and Regeneration, Chinese Academy of Medical Sciences, 100085, Beijing, China. zhyfeng@mail.sysu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH